#theravance

[moneyhealthfinance-blog]

Why Theravance Biopharma Shares Are Soaring

Why Theravance Biopharma Shares Are Soaring

Shares of Theravance Biopharma Inc. (NASDAQ: TBPH) saw a solid gain on Wednesday after the company announced a global collaboration with Johnson & Johnson (NYSE: JNJ) subsidiary, Janssen Biotech. The collaboration is for TD-1473 and related backup compounds for inflammatory intestinal diseases, including ulcerative colitis and Crohn’s disease. The plan is for Theravance together with Janssen to…

View On WordPress

[amcrasto]

TD 1607

TD-1607 Phase I A glycopeptide-cephalosporin heterodimer potentially for the treatment of gram-positive bacterial infection. CAS No. 827040-07-3 C95 H109 Cl3 N18 O31 S2,  Molecular Weight, 2169.47 Vancomycin,…

View On WordPress

[amcrasto]

GSK and Theravance announce Japanese approval for Anoro Ellipta

GSK and Theravance announce Japanese approval for Anoro Ellipta

GlaxoSmithKline (GSK) and Theravance have obtained approval from the Japanese Ministry of Health, Labour and Welfare for Anoro Ellipta to treat chronic obstructive pulmonary disease (COPD).

The Japanese approval for Anoro Ellipta is for the relief of various symptoms due to airway obstruction with COPDs, in the case where concurrent use of long-acting inhaled muscarinic antagonist and long-acting…

View On WordPress